Earnings To Watch: Insulet (PODD) Reports Q4 Results Tomorrow

robot
Abstract generation in progress

Insulet Corporation (PODD) is set to report its Q4 earnings on Wednesday morning, with analysts expecting a 28.6% year-on-year revenue growth to $768.2 million and adjusted earnings of $1.46 per share. The company has consistently beaten revenue estimates in the past two years, and its peers like ResMed and DexCom have also shown positive Q4 results. Despite some market underperformance in the healthcare equipment sector, Insulet maintains a strong average analyst price target.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
0/400
No comments
  • Pin